Morocco Continues Chloroquine Use Despite WHO Suspension and Safety Concerns

Chloroquine treatment is the subject of much criticism following the damning report of a study on the risks associated with its use. While the WHO has decided to temporarily suspend clinical trials with hydroxychloroquine, Morocco maintains its use.
For a member of the government, "opinions differ" on the subject. According to him, the essential thing is that chloroquine intervenes in viral inactivation. "The virus infects the host by entering the cell in several stages. One of the stages is inhibited by chloroquine," he insisted.
At the beginning of this month, the minister announced on television that the use of chloroquine "gives good results". According to Aït Tayeb, the observation on the ground is the same regarding the effectiveness of the treatment.
"It’s not just us who say so, but the same observation is made internationally. We have noticed since the adoption of this treatment on March 23 that patients recover faster than those admitted to the hospital before them," he points out. He also adds that this protocol can reduce the viral load in 6 or 7 days, in addition to allowing the patient not to go to intensive care.
Related Articles
-
Viral Video Sparks Debate on Taxi Regulation in Morocco After British Tourists’ Ordeal
3 June 2025
-
Moroccan Bank Glitch Causes Panic as Clients’ Accounts Show Zero Balance
3 June 2025
-
Moroccan Peppers Pulled from French Market Over Pesticide Concerns
3 June 2025
-
Morocco Court Convicts Four in Pregnant Woman Coffin Transport Scandal
2 June 2025
-
Morocco Probes Foreign Firms’ Financial Transfers Amid Tax Scrutiny
2 June 2025